Arcadia Biosciences Inc
RKDA
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.49M
Close$
$5.03
403% upside
Current Fair Value
403% upsideUndervalued by 403% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.49 Million |
|---|---|
| Enterprise Value | $539,006.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.71 |
| Beta | 0.52 |
| Outstanding Shares | 1,368,057 |
Return
| Return on Equity | -323.15% |
|---|---|
| Return on Assets | -175.15% |
| Return on Invested Capital | -184.18% |
Valuation & Multiples
| P/E Ratio | -0.14 |
|---|---|
| PEG | 0.05 |
| Price to Sales | 0.33 |
| Price to Book Ratio | 0.5 |
| Enterprise Value to Revenue | 0.11 |
| Enterprise Value to EBIT | -0.07 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.80
Average shareholder expectationRevenue Estimate
$1.60 M
Average shareholder expectationNext Earnings Call
Expected Date
August 19, 2026
EPS Estimate
$-0.56
Average shareholder expectationRevenue Estimate
$1.90 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 25.54%▲ 22.68% |
|---|---|
| Total Invested | $482,143▲ 522.57% |
| Investors Holding | 15▲ 2.00% |
ESG Score
No data